针对癌症代谢:脂肪酸合成酶 (FASN) 抑制剂的治疗潜力
Pier Vitale Nuzzo1, Silvia Rodrigues1, Caroline Fidalgo Ribeiro1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Critical reviews in oncology/hematology
|August 22, 2025
概括
脂肪酸合成酶 (FASN) 对癌症生长至关重要. 抑制FASN会扰乱癌症的新陈代谢,这是一种有前途的治疗策略,尤其是在与其他治疗相结合时.
科学领域:
- 生物化学
- 癌症学
- 代谢途径
背景情况:
- 代谢重组是癌症的一个关键特征.
- 脂肪酸合成酶 (FASN) 在许多癌症中是上调的,与预后不佳相关.
- 这对瘤细胞的增殖和生存至关重要.
研究的目的:
- 审查FASN在癌症代谢中的作用.
- 评估FASN抑制剂的治疗潜力.
- 讨论FASN在癌症中的结构,功能和调节.
主要方法:
- 对FASN在癌症中的作用的文献综述.
- 对各种癌症 (肺,结肠,大脑,乳腺,前列腺) 的FASN过度表达的分析.
- 对包括denifanstat (TVB- 2640) 在内的FASN抑制剂的临床前和临床数据的研究.
主要成果:
- 抑制FASN会破坏脂质生物合成,从而诱导癌细胞的代谢应激和亡.
- 在临床前模型中,Denifanstat显示出抗瘤活性,早期临床结果很有希望.
- 阻断FASN会影响瘤的生长,并提高化疗和向药物的疗效.
结论:
- FASN是癌症治疗的关键目标.
- 选择性FASN抑制剂如denifanstat具有显著的治疗潜力.
- 涉及FASN抑制剂的组合治疗可能会改善治疗结果,因此需要确定生物标志物来选择患者.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Overview of Fatty Acid Metabolism
31.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.7K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K


![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)